News & Announcements
-
Notice of AGM
/**/ RNS Number : 3203Y IQ-AI Limited 03 May 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) Notice of AGM IQ-AI Limited announces that notice of the annual general meeting of the Company, to be held at Third Floor, Forum 4, Grenville Street, St Helier, Jersey, JE2 4UF on 23 May 2023
-
Final Results
/**/ RNS Number : 4520X IQ-AI Limited 26 April 2023 26 April 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) Publication of Annual Report The Board of IQ-AI Ltd is pleased to announce the Company’s audited financial statements for the year ended 31 December 2022. The Annual Report will be available
-
Orphan Drug Designation Status
/**/ RNS Number : 3886R IQ-AI Limited 28 February 2023 IQ-AI Announces Orphan Drug Designation Status FDA grants orphan status to Gallium Maltolate for treating GBM IQ-AI Limited, (LSE: IQAI) (OTCQB: IQAIF), is pleased to announce that the United States Food and Drug Administration (FDA) has granted orphan drug designation (ODD) status for gallium
-
Letter to Shareholders
/**/ RNS Number : 1496M IQ-AI Limited 10 January 2023 IQ-AI LIMITED ISSUES LETTER TO SHAREHOLDERS IQ-AI Limited (“IQAI”) (LSE: IQAI) (OTCQB: IQAIF) a developer and manufacturer of medical image processing platforms, has today released a letter to shareholders on behalf of Michael Schmainda, CEO of IQ-AI’s wholly-owned subsidiary Imaging Biometrics (the “Company”), covering several material
-
Holding in Company
/**/ RNS Number : 4535I IQ-AI Limited 02 December 2022 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to